Expression Analysis of α5 Integrin Subunit Reveals Its Upregulation as a Negative Prognostic Biomarker for Glioblastoma

Integrin α5β1 was suggested to be involved in glioblastoma (GBM) aggressiveness and treatment resistance through preclinical studies and genomic analysis in patients. However, further protein expression data are still required to confirm this hypothesis. In the present study, we investigated by immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Etienne-Selloum, Nelly, Prades, Julien, Bello-Roufai, Diana, Boone, Mathieu, Sevestre, Henri, Trudel, Stéphanie, Caillet, Pascal, Coutte, Alexandre, Desenclos, Christine, Constans, Jean-Marc, Martin, Sophie, Choulier, Laurence, Chauffert, Bruno, Dontenwill, Monique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465081/
https://www.ncbi.nlm.nih.gov/pubmed/34577582
http://dx.doi.org/10.3390/ph14090882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465081/
https://www.ncbi.nlm.nih.gov/pubmed/34577582
http://dx.doi.org/10.3390/ph14090882

Ejemplares similares